Free tool
Drug Trial Radar: Endocrinology and women's health
Last checked: Nov 20, 2026Latest source record: Mar 4, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
3
Not yet recruiting, industry sponsors, Endocrinology and women's health, Phase 1
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed172
3 trials
Showing 1 to 3, recently updated first.
- A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)Pivotal-lookingNot yet recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.Industry
NCT07450001 · 128 participants (planned) · Start Mar 6, 2026 · Primary completion Jul 18, 2028
Drug: GenSci134 Injection; Recombinant Human Growth Hormone Injection(Norditropin® FlexPro®) · For: Pediatric Growth Hormone Deficiency
Sites: Wuhan, China
- Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic InsomniaNot yet recruiting
Nyree PennIndustry
NCT06644573 · 100 participants (planned) · Start Nov 1, 2025 · Primary completion May 1, 2026
Drug: Diprivan (propofol), Astra-Zeneca · For: Chronic Insomnia; Sleep Deprivation; REM Behavior Disorder and 34 more
Sites: Aventura, Florida
Changchun GeneScience Pharmaceutical Co., Ltd.Industry
NCT06840691 · 87 participants (planned) · Start May 2025 · Primary completion May 2025
Drug: PEG-rhGH with new preparation (T); PEG-rhGH with present preparation (T) · For: Pediatric Growth Hormone Deficiency (PGHD)
Sites: Chengdu, China
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.